Evidence map›Paper›PMID 32431898›Full record

ArticleRoyal Society open science2020

Design, synthesis, molecular modelling and

Adel Amer, Abdelrahman H Hegazi, Mohammed Khalil Alshekh, Hany E A Ahmed, Saied M Soliman, Antonin Maniquet, Rona R Ramsay

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Royal Society open science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Adel AmerDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Munawarah, Saudi Arabia.ORCID 0000-0003-0481-475X
Abdelrahman H HegaziDepartment of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt.ORCID 0000-0003-1364-676X
Mohammed Khalil AlshekhDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Munawarah, Saudi Arabia.
Hany E A AhmedPharmacognosy and Pharmaceutical Chemistry Department, Pharmacy College, Taibah University, Al-Madinha Al-Munawarah, Saudi Arabia.
Saied M SolimanDepartment of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt.ORCID 0000-0001-8405-8370
Antonin ManiquetBiomedical Sciences Research Complex, University of St Andrews, Biomolecular Sciences Building, North Haugh, St Andrews KY16 9ST, UK.
Rona R RamsayBiomedical Sciences Research Complex, University of St Andrews, Biomolecular Sciences Building, North Haugh, St Andrews KY16 9ST, UK.ORCID 0000-0003-1535-4904
Alexandria University · EGTaibah University · SAUniversity of St Andrews · GBAl-Azhar University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new series of N'-substituted benzylidene-2-(4-oxo-2-phenyl-1,4-dihydroquinazolin-3(2H)-yl)acetohydrazide (

Indexed as

antidepressantmonoamine oxidase inhibitorsquinazoline analoguesstructure–activity relationships

Identifiers

PMID32431898
PMCPMC7211837
OpenAlexW3019110035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.